PAIN
Volume 145, Issue 1 , Pages 24-30 , September 2009

Placebo conditioning and placebo analgesia modulate a common brain network during pain anticipation and perception

  • Alison Watson

      Affiliations

    • Human Pain Research Group, University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
    • Corresponding Author InformationCorresponding author. Tel.: +44 161 206 4529.
  • ,
  • Wael El-Deredy

      Affiliations

    • School of Psychological Sciences, University of Manchester, Oxford Rd., Manchester M13 9PL, UK
  • ,
  • Gian Domenico Iannetti

      Affiliations

    • Department of Physiology, Anatomy and Genetics, University of Oxford, South Parks Road, OX1 3QX Oxford, UK
  • ,
  • Donna Lloyd

      Affiliations

    • School of Psychological Sciences, University of Manchester, Oxford Rd., Manchester M13 9PL, UK
  • ,
  • Irene Tracey

      Affiliations

    • Oxford Centre for Functional MRI of the Brain, Oxford University, Department of Clinical Neurology, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK
  • ,
  • Brent A. Vogt

      Affiliations

    • Department of Neuroscience and Physiology, SUNY Upstate Medical University and Cingulum NeuroSciences Institute, 750E. Adams Street, Syracuse, NY 13210, USA
  • ,
  • Valerie Nadeau

      Affiliations

    • Human Pain Research Group, University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK
  • ,
  • Anthony K.P. Jones

      Affiliations

    • Human Pain Research Group, University of Manchester Rheumatic Diseases Centre, Hope Hospital, Salford M6 8HD, UK

Received 13 October 2008 ,Revised 23 January 2009 ,Accepted 6 April 2009.

References 

  1. Beckmann CF, Jenkinson M, Smith SM. General multilevel linear modeling for group analysis in FMRI. Neuroimage. 2003;20:1052–1063
  2. Benedetti F. How the doctor’s words affect the patient’s brain. Eval Health Prof. 2002;25:369–386
  3. Benedetti F, Arduino C, Amanzio M. Somatotopic activation of opoid systems by target directed expectations of analgesia. J Neurosci. 1999;19:3639–3648
  4. Bingel U, Lorenz J, Schoell E, Weiller C, Buchel C. Mechanisms of placebo analgesia: rACC recruitment of a subcortical antinociceptive network. Pain. 2006;120:8–15
  5. Buchel C, Bornhovd K, Quante M, Glauche V, Bromm B, Weiller C. Dissociable neural responses related to pain intensity, stimulus intensity, and stimulus awareness within the anterior cingulate cortex: a parametric single-trial laser functional magnetic resonance imaging study. J Neurosci. 2002;22:970–976
  6. Casey KL, Svensson P, Morrow TJ, Raz J, Jone C, Minoshima S. Selective opiate modulation of nociceptive processing in the human brain. J Neurophysiol. 2000;84:525–533
  7. Charron J, Rainville P, Marchand S. Direct comparison of placebo effects on clinical and experimental pain. Clin J Pain. 2006;22:204–211
  8. Cohen JD, Perlstein WM, Braver TS, Nystrom LE, Noll DC, Jonides J, et al. Temporal dynamics of brain activation during a working memory task. Nature. 1997;386:604–608
  9. Craggs J, Price DD, Perlestein W, Verne GN, Robinson ME. The dynamic mechanisms of placebo induced analgesia: evidence of sustained and transient regional involvement. Pain. 2008;139:660–669
  10. Craggs JG, Price DD, Verne GN, Perlstein WM, Robinson MM. Functional brain interactions that serve cognitive-affective processing during pain and placebo analgesia. Neuroimage. 2007;38:720–729
  11. Forman SD, Cohen JD, Fitzgerald M, Eddy WF, Mintun MA, Noll DC. Improved assessment of significant activation in functional magnetic resonance imaging (fMRI): use of a cluster-size threshold. Magn Reson Med. 1995;33:636–647
  12. Friston K, Worsley K, Frackowiak R, Mazziotta J, Evans A. Assessing the significance of focal activations using their spatial extent. Hum Brain Mapp. 1992;1:214–220
  13. Gu X, Han S. Attention and reality constraints on the neural processes of empathy for pain. Neuroimage. 2007;36:256–267
  14. Gu X, Han S. Neural substrates underlying evaluation of pain in actions depicted in words. Behav Brain Res. 2007;181:218–223
  15. Jenkinson M, Bannister P, Brady M, Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002;17:825–841
  16. Kaptchuk TJ, Goldman P, Stone DA, Stason WB. Do medical devices have enhanced placebo effects?. J Clin Epidemiol. 2000;53:786–792
  17. Kong J, Kaptchuk TJ, Polich G, Kirsch I, Gollub RL. Placebo analgesia: findings from brain imaging studies and emerging hypotheses. Rev Neurosci. 2007;18:173–190
  18. Kong J, White NS, Kwong KK, Vangel MG, Rosman IS, Gracely RH, et al. Using fMRI to dissociate sensory encoding from cognitive evaluation of heat pain intensity. Hum Brain Mapp. 2006;27:715–721
  19. Kong J, Gollub RL, Rosman IS, Webb JM, Vangel MG, Kirsch I, et al. Brain activity associated with expectancy-enhanced placebo analgesia as measured by functional magnetic resonance imaging. J Neurosci. 2006;26:381–388
  20. Kulkarni B, Bentley DE, Elliott R, Youell P, Watson A, Derbyshire SW, et al. Attention to pain localization and unpleasantness discriminates the functions of the medial and lateral pain systems. Eur J Neurosci. 2005;21:3133–3142
  21. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, Mandelkern M, et al. The neural correlates of placebo effects: a disruption account. Neuroimage. 2004;22:447–455
  22. Lieberman MD, Jarcho JM, Berman S, Naliboff BD, Suyenobu BY, Mandelkern M, et al. The neural correlates of placebo effects: a disruption account 1. NeuroImage. 2004;22:447–455
  23. Lorenz J, Minoshima S, Casey KL. Keeping pain out of mind: the role of the dorsolateral prefrontal cortex in pain modulation. Brain. 2003;126:1079–1091
  24. Morrison I, Peelen MV, Downing PE. The sight of others’ pain modulates motor processing in human cingulate cortex. Cereb Cortex. 2007;17:2214–2222
  25. Peng DL, Ding GS, Perry C, Xu D, Jin Z, Luo Q, et al. fMRI evidence for the automatic phonological activation of briefly presented words. Brain Res Cogn Brain Res. 2004;20:156–164
  26. Petrovic P, Ingvar M. Placebo and opioid analgesia imaging a shared neuronal network. Science. 2002;295:1737–1740
  27. Peyron R, Laurent B, Garcia-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis (2000). Clin Neurophysiol. 2000;30:263–288
  28. Price DD, Milling LS, Kirsch I, Duff A, Montgomery GH, Nicholls SS. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain. 1999;83:147–156
  29. Rainville P. Brain mechanisms of pain affect and pain modulation. Curr Opin Neurobiol. 2002;12:195–204
  30. Rescorla RA. Pavlovian conditioning, its not what you think it is. Am Psychol. 1988;43:151–160
  31. Rolls ET. Memory systems in the brain. Annu Rev Psychol. 2000;51:599–630
  32. Smith SM. Fast robust automated brain extraction. Hum Brain Mapp. 2002;17:143–155
  33. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H, et al. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004;23:S208–S219
  34. Vase L, Robinson ME, Verne GN, Price DD. The contributions of suggestion, desire, and expectation to placebo effects in irritable bowel syndrome patients: an empirical investigation. Pain. 2003;105:17–25
  35. Vase L, Robinson ME, Verne GN, Price DD. Increased placebo analgesia over time in irritable bowel syndrome (IBS) patients is associated with desire and expectation but not endogenous opioid mechanisms. Pain. 2005;115:338–347
  36. Verne GN, Himes NC, Robinson ME, Gopinath KS, Briggs RW, Crosson B, et al. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain. 2003;103:99–110
  37. Vogt BA. Pain and emotion interactions in subregions of the cingulate gyrus. Nat Rev Neurosci. 2005;6:533–544
  38. Vogt BA, Berger GR, Derbyshire SW. Structural and functional dichotomy of human midcingulate cortex. Eur J Neurosci. 2003;18:3134–3144
  39. Voudouris NJ, Peck CL, Coleman G. Conditioned placebo responses. J Pers Soc Psychol. 1985;48:47–53
  40. Voudouris NJ. Conditioned response models of placebo phenomena: further support. Pain. 1989;38:109–116
  41. Voudouris NJ. The role of conditioning and verbal expectancy in the placebo response. Pain. 1990;43:121–128
  42. Wager TD, Matre D, Casey KL. Placebo effects in laser-evoked pain potentials. Brain Behav Immun. 2006;20:219–230
  43. Wager TD, Rilling JK, Smith EE, Sokolik A, Casey KL, Davidson RJ, et al. Placebo-induced changes in fMRI in the anticipation and experience of pain. Science. 2004;303:1162–1167
  44. Watson A, El-Deredy W, Bentley DE, Vogt BA, Jones AKP. Categories of placebo response in the absence of site-specific expectation of analgesia. Pain. 2006;126:115–122
  45. Watson A, El-Deredy W, Vogt BA, Jones AK. Placebo analgesia is not due to compliance or habituation: EEG and behavioural evidence. Neuroreport. 2007;18:771–775
  46. Woolrich MW, Behrens TE, Beckmann CF, Jenkinson M, Smith SM. Multilevel linear modelling for FMRI group analysis using Bayesian inference. Neuroimage. 2004;21:1732–1747
  47. Woolrich MW, Ripley BD, Brady M, Smith SM. Temporal autocorrelation in univariate linear modeling of FMRI data. Neuroimage. 2001;14:1370–1386
  48. Worsley KJ, Evans AC, Marrett S, Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J Cereb Blood Flow Metab. 1992;12:900–918
  49. Zubieta JK, Bueller JA, Jackson LR, Scott DJ, Xu Y, Koeppe RA, et al. Placebo effects mediated by endogenous opioid activity on {micro}-opioid receptors. J Neurosci. 2005;25:7754–7762

PII: S0304-3959(09)00209-7

doi: 10.1016/j.pain.2009.04.003

PAIN
Volume 145, Issue 1 , Pages 24-30 , September 2009